1
Back to Glossary
Ecosystem
Pharmacovigilance Glossary

EMA (European Medicines Agency)

Picture every country's national weather service feeding its local readings up to one central meteorological office, which then issues the one forecast everyone actually acts on. EMA plays roughly that same role for medicine safety across the EU.

What is it?

EMA is the EU agency responsible for the scientific evaluation, supervision, and safety monitoring of medicines across all member states. It doesn't replace national authorities so much as coordinate them: committees like PRAC, which handles safety, and CHMP, which handles product approval, sit inside EMA's structure, built from experts each country's NCA nominates.

National data flows up into EMA's system, and EU-wide decisions flow back out: authorizations, label changes, safety communications. Those decisions still typically get formally adopted at national level, which is why NCAs stay very much in the loop rather than being sidelined by a centralized agency.

What flows through EMA

Hover an item on either side to see what it involves.

Hover an item to see what flows through it
Flows In
National Reports
Case data and safety concerns surfaced through each country's own NCA.
New Applications
Marketing authorization applications submitted for EU-wide evaluation.
Signal Reviews
Cases flagged through disproportionality analysis, escalated for committee assessment.
→
EMA
→
Flows Out
Marketing Authorizations
EU-wide approvals granted once CHMP's scientific review is complete.
Safety Communications
Label updates, Black Triangle additions, and public safety alerts.
Referral Decisions
Formal outcomes on serious concerns, up to and including market suspension.

Common Misconceptions

Myth

"EMA is basically the EU's version of the FDA, one top-down authority that overrides individual countries?"

Truth

Not quite. EMA works through a networked model built on national authorities: its committees are staffed by experts each NCA nominates, and many of its recommendations still need formal national-level adoption rather than taking effect on EMA's word alone.